Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
Anthony V D'Amico, Judd Moul, Peter R Carroll, et al.
The Journal of Urology
|
November 13, 2004
Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy
Anthony V D'Amico, Judd Moul, Peter R Carroll, et al.
World Journal of Surgery
|
April 9, 2005
Wound healing enhancement: electroporation to address a classic problem of military medicine
Mark Ferguson, Colman Byrnes, Leon Sun, et al.
Urology
|
February 13, 2008
Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?
Vladimir Mouraviev, Gloria Broadwater, Leon Sun, et al.
The Journal of Urology
|
April 12, 2005
Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer
Anthony V D'Amico, Judd Moul, Peter R Carroll, et al.
Urologic Oncology
|
May 20, 2009
Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
Janice M Mayes, Vladimir Mouraviev, Leon Sun, et al.
The Journal of Urology
|
June 15, 2007
Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy
Hubert R Kübler, Timothy Y Tseng, Leon Sun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 18, 2011
Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers
Bridget F Koontz, Matvey Tsivian, Vladimir Mouraviev, et al.
Cancer
|
July 1, 2010
Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience
Ping Tang, Leon Sun, Matthew A Uhlman, et al.
Cancer
|
June 26, 2007
Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer
Vladimir Mouraviev, Janice M Mayes, Leon Sun, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
Anthony V D'Amico, Judd Moul, Peter R Carroll, et al.
The Journal of Urology
|
November 13, 2004
Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy
Anthony V D'Amico, Judd Moul, Peter R Carroll, et al.
World Journal of Surgery
|
April 9, 2005
Wound healing enhancement: electroporation to address a classic problem of military medicine
Mark Ferguson, Colman Byrnes, Leon Sun, et al.
Urology
|
February 13, 2008
Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?
Vladimir Mouraviev, Gloria Broadwater, Leon Sun, et al.
The Journal of Urology
|
April 12, 2005
Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer
Anthony V D'Amico, Judd Moul, Peter R Carroll, et al.
Urologic Oncology
|
May 20, 2009
Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
Janice M Mayes, Vladimir Mouraviev, Leon Sun, et al.
The Journal of Urology
|
June 15, 2007
Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy
Hubert R Kübler, Timothy Y Tseng, Leon Sun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 18, 2011
Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers
Bridget F Koontz, Matvey Tsivian, Vladimir Mouraviev, et al.
Cancer
|
July 1, 2010
Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience
Ping Tang, Leon Sun, Matthew A Uhlman, et al.
Cancer
|
June 26, 2007
Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer
Vladimir Mouraviev, Janice M Mayes, Leon Sun, et al.
Page
of 10